Table 3.
Site | Tumour | ICD-O code | Number of cases | Dog-years | IR | 95% CI |
---|---|---|---|---|---|---|
Mammary gland | Complex Carcinoma | 8010/3 | 60 | 31,113 | 193 | 147–248 |
Carcinoma Simplex | 8231/3 | 36 | 31,113 | 116 | 81–160 | |
Tubulopapillary Carcinoma | 8263/3 | 18 | 31,113 | 58 | 34–91 | |
Carcinoma In Situ | 8010/2 | 18 | 31,113 | 58 | 34–91 | |
Solid Carcinoma | 8230/3 | 16 | 31,113 | 51 | 29–84 | |
Skin | Mastocytoma | 9740/3 | 73 | 68,865 | 106 | 83–133 |
Hemangiopericytoma | 9150/1 | 28 | 68,865 | 41 | 27–59 | |
Genital tract | Seminoma | 9061/3 | 25 | 37,748 | 66 | 43–98 |
Sertoli Cell Tumour | 8640/1 | 13 | 37,748 | 34 | 18–59 | |
Spleen | Hemangiosarcoma | 9120/3 | 13 | 68,865 | 19 | 10–32 |
Incidence rates of malignant tumours (cases per 100,000 dog-years at risk) by histological type and site (only the higher incidence rates are shown). CI denotes confidence interval, IR incidence rate ICD-O International Classification of Diseases for Oncology